HI
EVH icon

Harbour Investments’s Evolent Health EVH Stock Holding History

Harbour Investments’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Sell
2,000
-540
-21% -$2.07K ﹤0.01% 3317
2026
Q1 		$5.79K Buy
2,540
+315
+14% +$999 ﹤0.01% 3525
2025
Q4 		$8.9K Sell
2,225
-438
-16% -$2.44K ﹤0.01% 2795
2025
Q3 		$22.5K Sell
2,663
-175
-6% -$1.7K ﹤0.01% 2273
2025
Q2 		$32K Sell
2,838
-1,490
-34% -$13.7K ﹤0.01% 2017
2025
Q1 		$41K Sell
4,328
-5,860
-58% -$59.2K ﹤0.01% 1856
2024
Q4 		$115K Sell
10,188
-3,188
-24% -$56K ﹤0.01% 1299
2024
Q3 		$378K Sell
13,376
-340
-2% -$8.76K 0.01% 765
2024
Q2 		$262K Sell
13,716
-175
-1% -$4.47K 0.01% 840
2024
Q1 		$455K Buy
13,891
+660
+5% +$21.1K 0.02% 627
2023
Q4 		$437K Buy
13,231
+145
+1% +$4.1K 0.02% 573
2023
Q3 		$356K Sell
13,086
-500
-4% -$13.9K 0.02% 593
2023
Q2 		$412K Sell
13,586
-175
-1% -$5.66K 0.02% 548
2023
Q1 		$447K Sell
13,761
-75
-0.5% -$2.37K 0.02% 504
2022
Q4 		$389K Sell
13,836
-820
-6% -$23.5K 0.02% 524
2022
Q3 		$450K Hold
14,656
– – 0.03% 442
2022
Q2 		$450K Buy
+14,656
New +$427K 0.03% 442
2021
Q4 		$393K Sell
14,186
-2,885
-17% -$82.8K 0.02% 488
2021
Q3 		$529K Sell
17,071
-21,176
-55% -$508K 0.02% 624
2021
Q2 		$808K Buy
38,247
+890
+2% +$17.8K 0.03% 510
2021
Q1 		$755K Buy
+37,357
New +$710K 0.03% 473

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Harbour Investments's EVH Position: Q2 2026 in Review

Harbour Investments reduced its Evolent Health (EVH) stake by 21% in Q2 2026, selling an estimated $2.07K and leaving 2,000 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3317.

Harbour Investments first reported a position in EVH in Q1 2021 and has held it in 21 quarters since. The position peaked at $808K in Q2 2021. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Harbour Investments held 2,000 shares of Evolent Health worth $10.8K as of Q2 2026.
  • Harbour Investments sold 540 Evolent Health shares in Q2 2026, an estimated $2.07K.
  • Evolent Health made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3317 holding.
  • Harbour Investments first reported a position in Evolent Health in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Evolent Health position peaked at $808K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.